Canadian DIN & Molecule SearchMolecules A–ZDrug ShortagesResourcesHealth Canada WeeklyRequest a Quote

BLEOMYCIN FOR INJECTION DIN 02566346

Status: Approved
Holder: MARCAN PHARMACEUTICALS INC
Molecule: BLEOMYCIN (BLEOMYCIN SULFATE)

Health Canada record

Active ingredient(s)BLEOMYCIN (BLEOMYCIN SULFATE) 15 UNIT
Dosage formPowder For Solution
RouteSubcutaneous; Intrapleural; Intravenous; Intramuscular
SchedulePRESCRIPTION
ClassHuman
ATCL01DC01 BLEOMYCIN
Original market date
Current status date03-Mar-2026
SourceHealth Canada DPD

Establishment licence of the holder

Marcan Pharmaceuticals Inc. — licence 101909, currently licensed, last inspection rating C (2024-05-21).

No Canadian shortage report is currently matched to this DIN.

Other Canadian products containing BLEOMYCIN (BLEOMYCIN SULFATE)

DINProductCompanyFormStrengthStatus
02265982BLEOMYCIN FOR INJECTIONFRESENIUS KABI CANADA LTDPowder For SolutionBLEOMYCIN (BLEOMYCIN SULFATE) 15 UNITMarketed
02131692BLEOMYCIN FOR INJECTION USPPFIZER CANADA ULCPowder For SolutionBLEOMYCIN (BLEOMYCIN SULFATE) 15 UNITMarketed
02367351BLEOMYCIN FOR INJECTION USPSANDOZ CANADA INCORPORATEDPowder For SolutionBLEOMYCIN (BLEOMYCIN SULFATE) 15 UNITCancelled Pre Market

Notices of Compliance

NOCDateSubmissionReason
370362026-03-03Abbreviated New Drug Submission (ANDS)
Request a quote for BLEOMYCIN FOR INJECTION

How to read a Canadian DIN record